These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36875175)

  • 1. Concordance between Ov16 Rapid Diagnostic Test(RDT) and Ov16 Enzyme-Linked Immunosorbent Assay (ELISA) for the Diagnosis of Onchocerciasis in Areas of Contrasting Endemicity in Cameroon.
    Ekanya R; Beng AA; Anim MA; Pangwoh YZ; Dibando OE; Gandjui NVT; Awah AR; Amambo GN; Nchanji GT; Ndzeshang BL; Nji TM; Fombad FF; Njouendou AJ; Eyong EM; Cho JF; Eyong PA; Deribe K; Ngum NH; Golden A; Wanji S
    Parasite Epidemiol Control; 2023 May; 21():e00290. PubMed ID: 36875175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Diagnostic Tests for
    Hotterbeekx A; Perneel J; Mandro M; Abhafule G; Siewe Fodjo JN; Dusabimana A; Abrams S; Kumar-Singh S; Colebunders R
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32498284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
    Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso.
    Nikièma AS; Koala L; Unnasch TR; Diendéré J; Compaoré J; Ouédraogo MW; Kafando CM; Bakajika D; Bougouma C; Faye B; Traoré S; Dabiré RK
    Parasite Epidemiol Control; 2024 May; 25():e00352. PubMed ID: 38708128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.
    Herrador Z; Garcia B; Ncogo P; Perteguer MJ; Rubio JM; Rivas E; Cimas M; Ordoñez G; de Pablos S; Hernández-González A; Nguema R; Moya L; Romay-Barja M; Garate T; Barbre K; Benito A
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006471. PubMed ID: 29723238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
    Golden A; Faulx D; Kalnoky M; Stevens E; Yokobe L; Peck R; Karabou P; Banla M; Rao R; Adade K; Gantin RG; Komlan K; Soboslay PT; de Los Santos T; Domingo GJ
    Parasit Vectors; 2016 Jun; 9(1):338. PubMed ID: 27296630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
    Golden A; Stevens EJ; Yokobe L; Faulx D; Kalnoky M; Peck R; Valdez M; Steel C; Karabou P; Banla M; Soboslay PT; Adade K; Tekle AH; Cama VA; Fischer PU; Nutman TB; Unnasch TR; de los Santos T; Domingo GJ
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004292. PubMed ID: 26745374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening.
    Dusabimana A; Siewe Fodjo JN; Ndahura MM; Mmbando BP; Jada SR; Boven A; De Smet E; Ukety T; Njamnshi AK; Laudisoit A; Abrams S; Colebunders R
    Pathogens; 2022 Feb; 11(3):. PubMed ID: 35335605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.
    Steel C; Golden A; Stevens E; Yokobe L; Domingo GJ; de los Santos T; Nutman TB
    Clin Vaccine Immunol; 2015 Aug; 22(8):896-901. PubMed ID: 26018537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal.
    Dieye Y; Storey HL; Barrett KL; Gerth-Guyette E; Di Giorgio L; Golden A; Faulx D; Kalnoky M; Ndiaye MKN; Sy N; Mané M; Faye B; Sarr M; Dioukhane EM; Peck RB; Guinot P; de Los Santos T
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005884. PubMed ID: 28972982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Hypoendemic Onchocerciasis in
    Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
    Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
    Dolo H; Coulibaly YI; Sow M; Dembélé M; Doumbia SS; Coulibaly SY; Sangare MB; Dicko I; Diallo AA; Soumaoro L; Coulibaly ME; Diarra D; Colebunders R; Nutman TB; Walker M; Basáñez MG
    Clin Infect Dis; 2021 May; 72(9):1585-1593. PubMed ID: 32206773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
    Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey.
    Hadermann A; Jada SR; Amaral LJ; Colebunders R; Bol YY; Siewe Fodjo JN
    Open Res Eur; 2023; 3():206. PubMed ID: 38617116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
    Lont YL; Coffeng LE; de Vlas SJ; Golden A; de Los Santos T; Domingo GJ; Stolk WA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005314. PubMed ID: 28114304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
    Dolo H; Coulibaly YI; Dembele B; Guindo B; Coulibaly SY; Dicko I; Doumbia SS; Dembele M; Traore MO; Goita S; Dolo M; Soumaoro L; Coulibaly ME; Diallo AA; Diarra D; Zhang Y; Colebunders R; Nutman TB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007064. PubMed ID: 30699120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study.
    Dusabimana A; Bhwana D; Mandro M; Mmbando BP; Siewe Fodjo JN; Colebunders R
    Pathogens; 2020 Oct; 9(10):. PubMed ID: 33081184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
    Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis.
    Coffeng LE; Stolk WA; Golden A; de Los Santos T; Domingo GJ; de Vlas SJ
    Am J Epidemiol; 2019 Sep; 188(9):1723-1732. PubMed ID: 31062838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.